(Total Views: 319)
Posted On: 12/10/2021 8:30:47 AM
Post# of 190

$PFE News Article - Arvinas and Pfizer Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer https://marketwirenews.com/news-releases/arvi...81645.html


My Twitter: WhyteStocks